BIOLOGICAL · Unmapped registry intervention
Agrippal S1 (Influenza vaccination)
Find medicine records ·
Find other trials using this name
Clinical trial
Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis
NCT01002716
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedCell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Agrippal S1 (Influenza vaccination)BIOLOGICAL
Sponsors & collaborators
Tel-Aviv Sourasky Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01002716 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.